Meridian Bioscience Reports Third Quarter and Nine Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2015 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. DPZ
7. NVDA
8. PRIM
9. META
10. SPY

Go back to Meridian Bioscience Reports Third Quarter and Nine Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2015 Guidance

Canaccord Genuity Cuts Price Target on Meridian Bioscience (VIVO) Following In-Line Quarter Results

July 27, 2015 9:18 AM EDT

Canaccord Genuity reiterated a Hold rating on Meridian Biosciences (NASDAQ: VIVO), and cut the price target to $19.00 (from $20.00), following quarterly results. Revenues of $48.3M narrowly missed the Street's $48.6M. EPS of $0.22 was in line with the Street.

Analyst Mark Massaro... More

Meridian Bioscience (VIVO) Declares $0.20 Quarterly Dividend; 4.1% Yield

July 23, 2015 8:26 AM EDT

Meridian Bioscience (Nasdaq: VIVO) declared a quarterly dividend of $0.20 per share, or $0.8 annualized.

The dividend will be payable on August 13, 2015, to stockholders of record on August 3, 2015, with an ex-dividend date of July 30, 2015.

The annual yield on the dividend is 4.1 percent.

For... More

Meridian Bioscience (VIVO) Reports In-Line Q2 EPS

July 23, 2015 8:26 AM EDT

Meridian Bioscience (NASDAQ: VIVO) reported Q2 EPS of $0.22, in-line with the analyst estimate of $0.22. Revenue for the quarter came in at $48.2 million versus the consensus estimate of $48.6 million.

For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.

... More